4.7 Article

Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites

期刊

BLOOD
卷 115, 期 22, 页码 4559-4568

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-09-243725

关键词

-

资金

  1. National Health and Medical Research Council of Australia
  2. Postgraduate Research Fellowships
  3. Independent Research Institutes
  4. Australian Government
  5. University of Melbourne
  6. Victorian State Government
  7. Wellcome Trust

向作者/读者索取更多资源

During erythrocyte invasion, Plasmodium falciparum merozoites use multiple receptor-ligand interactions in a series of coordinated events, but current knowledge of these interactions is limited. Using real-time imaging of invasion, we established that heparin-like molecules block early, and essential, events in erythrocyte invasion by merozoites. All P falciparum isolates tested, and parasites using different invasion pathways were inhibited to comparable levels. Furthermore, it was not possible to select for heparin-resistant parasites. Heparin-like molecules occur naturally on the surface of human erythrocytes, where they may act as receptors for binding of merozoite surface proteins. Consistent with this, we demonstrated that MSP1-42, a processed form of merozoite surface protein 1 (MSP1) involved in invasion, bound heparin in a specific manner; furthermore, binding was observed with the secondary processing fragment MSP1-33, but not MSP1-19. We defined key structural requirements of heparin-like molecules for invasion inhibition and interactions with MSP1-42. Optimal activity required a degree of sulfation more than or equal to 2, disulfation of the N-acetylglucosamine or hexuronic acid residue, and a minimum chain length of 6 monosaccharides. These findings have significant implications for understanding P falciparum invasion of erythrocytes and the development of novel therapeutics and vaccines. (Blood. 2010; 115(22): 4559-4568)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据